StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
KURA

Kura Oncology, Inc.

KURA Nasdaq Pharmaceutical Preparations EDGAR ↗
$9.19
-0.12 -1.29%

Key statistics

from XBRL data in SEC filings
Market cap
$816M
Revenue (TTM)
$71.6M
Net income (TTM)
-$295M
EPS (TTM)
$-3.35
P/E ratio
Dividend yield
Free cash flow
-$70.7M
Cash
$39.1M
Total assets
$653M
Gross margin
52-week range
$5.45 – $12.49

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 29, 2026 8-K Director or officer change; Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Amended charter or bylaws Jan 29, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Other events Dec 2, 2025 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Other events Oct 24, 2025 8-K Other events Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement Jul 1, 2025 8-K Other events Jun 18, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 8-K Other events Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Other events Feb 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 14, 2025 8-K Director or officer change; Other events Jan 6, 2025 8-K Other events Dec 20, 2024 8-K Entered a material agreement Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Shareholder vote results Jun 7, 2024 8-K Other events May 24, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024